← All investors

ARCH Venture Partners

VC🇺🇸 United States

Investment thesis

Science-first, contrarian investor that co-founds companies at the concept stage by identifying breakthrough science, recruiting management teams and providing patient capital. Sizes investments to the opportunity rather than fund constraints.

Notable portfolio

IlluminaAlnylam PharmaceuticalsBluebird Bio

Sector focus

Life sciencesBiotechTherapeuticsPrecision medicineDiagnosticsDeep science